Research Summary
Oral proteins and peptides are biologically active molecules that are administered through oral ingestion, allowing them to be absorbed and exert their therapeutic effects within the human body. These substances can include proteins, peptides, and antibodies designed to treat various medical conditions. Developing effective oral protein and peptide formulations is a significant challenge due to the digestive processes in the gastrointestinal tract. However, research and innovations in drug delivery technologies, such as nanoparticles, oral capsules, and mucoadhesive formulations, have expanded the possibilities of oral administration for these therapeutic molecules. This approach offers the advantage of non-invasive drug delivery and enhanced patient compliance, particularly for long-term treatments, as it eliminates the need for injections or intravenous infusions. It has the potential to revolutionize the treatment of conditions ranging from diabetes to autoimmune diseases, offering more convenient and patient-friendly options for managing various medical disorders.
According to DIResearch's in-depth investigation and research, the global Oral Proteins and Peptides market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Oral Proteins and Peptides include Ironwood & Allergan, Novo Nordisk, Synergy Pharma, Novartis, Amryt Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Oral Proteins and Peptides. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oral Proteins and Peptides market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Oral Proteins and Peptides market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oral Proteins and Peptides industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Oral Proteins and Peptides Include:
Ironwood & Allergan
Novo Nordisk
Synergy Pharma
Novartis
Amryt Pharma
Oral Proteins and Peptides Product Segment Include:
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide
Oral Proteins and Peptides Product Application Include:
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Oral Proteins and Peptides Industry PESTEL Analysis
Chapter 3: Global Oral Proteins and Peptides Industry Porter's Five Forces Analysis
Chapter 4: Global Oral Proteins and Peptides Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Oral Proteins and Peptides Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Oral Proteins and Peptides Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Oral Proteins and Peptides Market Overview 1.1 Product Definition and Statistical Scope 1.2 Oral Proteins and Peptides Product by Type 1.2.1 Global Oral Proteins and Peptides Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Linaclotide 1.2.3 Insulin 1.2.4 Plecanatide 1.2.5 Cyclosporine 1.2.6 Octreotide 1.3 Oral Proteins and Peptides Product by Application 1.3.1 Global Oral Proteins and Peptides Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Gastric & Digestive Disorders 1.3.3 Bone Diseases 1.3.4 Diabetes 1.3.5 Hormonal Disorders 1.4 Global Oral Proteins and Peptides Market Revenue and Sales Analysis 1.4.1 Global Oral Proteins and Peptides Market Size Analysis (2019-2030) 1.4.2 Global Oral Proteins and Peptides Market Sales Analysis (2019-2030) 1.4.3 Global Oral Proteins and Peptides Market Sales Price Trend Analysis (2019-2030) 1.5 Oral Proteins and Peptides Market Development Status and Trends 1.5.1 Oral Proteins and Peptides Industry Development Status Analysis 1.5.2 Oral Proteins and Peptides Industry Development Trends Analysis 2 Oral Proteins and Peptides Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Oral Proteins and Peptides Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Oral Proteins and Peptides Market Analysis by Regions 4.1 Oral Proteins and Peptides Overall Market: 2023 VS 2024 VS 2030 4.2 Global Oral Proteins and Peptides Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Oral Proteins and Peptides Revenue and Market Share by Region (2019-2024) 4.2.2 Global Oral Proteins and Peptides Revenue Forecast by Region (2025-2030) 4.3 Global Oral Proteins and Peptides Sales and Forecast Analysis (2019-2030) 4.3.1 Global Oral Proteins and Peptides Sales and Market Share by Region (2019-2024) 4.3.2 Global Oral Proteins and Peptides Sales Forecast by Region (2025-2030) 4.4 Global Oral Proteins and Peptides Sales Price Trend Analysis (2019-2030) 5 Global Oral Proteins and Peptides Market Size by Type and Application 5.1 Global Oral Proteins and Peptides Market Size by Type 5.1.1 Global Oral Proteins and Peptides Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Oral Proteins and Peptides Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Oral Proteins and Peptides Market Size by Application 5.2.1 Global Oral Proteins and Peptides Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Oral Proteins and Peptides Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Oral Proteins and Peptides Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Oral Proteins and Peptides Market Size by Type 6.3.1 North America Oral Proteins and Peptides Sales by Type (2019-2030) 6.3.2 North America Oral Proteins and Peptides Revenue by Type (2019-2030) 6.4 North America Oral Proteins and Peptides Market Size by Application 6.4.1 North America Oral Proteins and Peptides Sales by Application (2019-2030) 6.4.2 North America Oral Proteins and Peptides Revenue by Application (2019-2030) 6.5 North America Oral Proteins and Peptides Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Oral Proteins and Peptides Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Oral Proteins and Peptides Market Size by Type 7.3.1 Europe Oral Proteins and Peptides Sales by Type (2019-2030) 7.3.2 Europe Oral Proteins and Peptides Revenue by Type (2019-2030) 7.4 Europe Oral Proteins and Peptides Market Size by Application 7.4.1 Europe Oral Proteins and Peptides Sales by Application (2019-2030) 7.4.2 ? Europe Oral Proteins and Peptides Revenue by Application (2019-2030) 7.5 Europe Oral Proteins and Peptides Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Oral Proteins and Peptides Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Oral Proteins and Peptides Market Size by Type 8.3.1 China Oral Proteins and Peptides Sales by Type (2019-2030) 8.3.2 China Oral Proteins and Peptides Revenue by Type (2019-2030) 8.4 China Oral Proteins and Peptides Market Size by Application 8.4.1 China Oral Proteins and Peptides Sales by Application (2019-2030) 8.4.2 China Oral Proteins and Peptides Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Oral Proteins and Peptides Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Oral Proteins and Peptides Market Size by Type 9.3.1 APAC (excl. China) Oral Proteins and Peptides Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Oral Proteins and Peptides Revenue by Type (2019-2030) 9.4 APAC (excl. China) Oral Proteins and Peptides Market Size by Application 9.4.1 APAC (excl. China) Oral Proteins and Peptides Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Oral Proteins and Peptides Revenue by Application (2019-2030) 9.5 APAC (excl. China) Oral Proteins and Peptides Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Oral Proteins and Peptides Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Oral Proteins and Peptides Market Size by Type 10.3.1 Latin America Oral Proteins and Peptides Sales by Type (2019-2030) 10.3.2 Latin America Oral Proteins and Peptides Revenue by Type (2019-2030) 10.4 Latin America Oral Proteins and Peptides Market Size by Application 10.4.1 Latin America Oral Proteins and Peptides Sales by Application (2019-2030) 10.4.2 Latin America Oral Proteins and Peptides Revenue by Application (2019-2030) 10.5 Latin America Oral Proteins and Peptides Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Oral Proteins and Peptides Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Oral Proteins and Peptides Market Size by Type 11.3.1 Middle East & Africa Oral Proteins and Peptides Sales by Type (2019-2030) 11.3.2 Middle East & Africa Oral Proteins and Peptides Revenue by Type (2019-2030) 11.4 Middle East & Africa Oral Proteins and Peptides Market Size by Application 11.4.1 Middle East & Africa Oral Proteins and Peptides Sales by Application (2019-2030) 11.4.2 Middle East & Africa Oral Proteins and Peptides Revenue by Application (2019-2030) 11.5 Middle East & Africa Oral Proteins and Peptides Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Oral Proteins and Peptides Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Oral Proteins and Peptides Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Oral Proteins and Peptides Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Oral Proteins and Peptides Average Sales Price by Manufacturers (2020-2024) 12.2 Oral Proteins and Peptides Competitive Landscape Analysis and Market Dynamic 12.2.1 Oral Proteins and Peptides Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Ironwood & Allergan 13.1.1 Ironwood & Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Ironwood & Allergan Oral Proteins and Peptides Product Portfolio 13.1.3 Ironwood & Allergan Oral Proteins and Peptides Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Novo Nordisk 13.2.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Novo Nordisk Oral Proteins and Peptides Product Portfolio 13.2.3 Novo Nordisk Oral Proteins and Peptides Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 Synergy Pharma 13.3.1 Synergy Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Synergy Pharma Oral Proteins and Peptides Product Portfolio 13.3.3 Synergy Pharma Oral Proteins and Peptides Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Novartis 13.4.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Novartis Oral Proteins and Peptides Product Portfolio 13.4.3 Novartis Oral Proteins and Peptides Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 Amryt Pharma 13.5.1 Amryt Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Amryt Pharma Oral Proteins and Peptides Product Portfolio 13.5.3 Amryt Pharma Oral Proteins and Peptides Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Oral Proteins and Peptides Industry Chain Analysis 14.2 Oral Proteins and Peptides Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Oral Proteins and Peptides Typical Downstream Customers 14.4 Oral Proteins and Peptides Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support